1. Home
  2. AUTL
  3. AUTL News

Latest Autolus Therapeutics plc (AUTL) News on November 16, 2025

How Investors Are Reacting To Autolus Therapeutics (AUTL) Trimming Losses and Appointing a New Finance Chief
AUTL

Simply Wall St.

3 days ago

How Investors Are Reacting To Autolus Therapeutics (AUTL) Trimming Losses and Appointing a New Finance Chief

Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
AUTL

GlobeNewswire

3 days ago

Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

AUTL

MT Newswires

3 days ago

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading

Autolus Therapeutics PLC (AUTL) Q3 2025 Earnings Call Highlights: Navigating Challenges and ...
AUTL

GuruFocus.com

4 days ago

Autolus Therapeutics PLC (AUTL) Q3 2025 Earnings Call Highlights: Navigating Challenges and ...

November 2025's Promising Penny Stocks To Watch
AUTL

Simply Wall St.

4 days ago

November 2025's Promising Penny Stocks To Watch

AUTL

MT Newswires

4 days ago

European Equities Traded in the US as American Depositary Receipts Rise Wednesday

Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
AUTL

GlobeNewswire

4 days ago

Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

AUTL

MT Newswires

5 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

AUTL

MT Newswires

6 days ago

European Equities Traded in the US as American Depositary Receipts Start Week Trending Higher in Monday Trading

AUTL

MT Newswires

12 days ago

European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025
AUTL

GlobeNewswire

13 days ago

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025

AUTL

MT Newswires

16 days ago

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

Why is Autolus Therapeutics plc (AUTL) One of the Best Stocks Under $5 With Highest Upside Potential?
AUTL

Insider Monkey

17 days ago

Why is Autolus Therapeutics plc (AUTL) One of the Best Stocks Under $5 With Highest Upside Potential?

AUTL

MT Newswires

17 days ago

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading

AUTL

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

AUTL

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

AUTL

MT Newswires

a month ago

Autolus Therapeutics Doses First Patient in Phase 1 Trial of Obe-cel for Progressive Multiple Sclerosis

AUTL

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Down in Friday Trading, Up for Week

AUTL

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AUTL

GlobeNewswire

a month ago

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

AUTL

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading

AUTL

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

AUTL

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

AUTL

MT Newswires

4 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

AUTL

MT Newswires

4 months ago

European Equities Traded in the US as American Depositary Receipts Advance in Tuesday Trading

AUTL

MT Newswires

4 months ago

European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading

AUTL

MT Newswires

5 months ago

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading

Needham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10
AUTL

Insider Monkey

5 months ago

Needham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10

AUTL

MT Newswires

5 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

Ardelyx Leads The Pack Of 3 Promising Penny Stocks
AUTL

Simply Wall St.

5 months ago

Ardelyx Leads The Pack Of 3 Promising Penny Stocks

AUTL

MT Newswires

5 months ago

European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading

AUTL

GuruFocus.com

5 months ago

Syncona Ltd (LSE:SYNC) Full Year 2025 Earnings Call Highlights: Navigating Market Challenges ...

AUTL

MT Newswires

5 months ago

European Equities Traded in the US as American Depositary Receipts Edge Higher Wednesday

AUTL

MT Newswires

5 months ago

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress
AUTL

GlobeNewswire

5 months ago

Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress

Autolus Therapeutics to Participate in Upcoming Investor Conferences
AUTL

GlobeNewswire

6 months ago

Autolus Therapeutics to Participate in Upcoming Investor Conferences

AUTL

MT Newswires

6 months ago

Autolus Therapeutics' Leukemia Therapy Gets Backing From European Medicines Agency

Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
AUTL

GlobeNewswire

6 months ago

Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

Autolus Therapeutics plc (AUTL): Analysts See 697% Upside Potential
AUTL

Insider Monkey

6 months ago

Autolus Therapeutics plc (AUTL): Analysts See 697% Upside Potential

Promising Penny Stocks To Watch In May 2025
AUTL

Simply Wall St.

6 months ago

Promising Penny Stocks To Watch In May 2025

Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress
AUTL

GlobeNewswire

6 months ago

Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress

Autolus Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
AUTL

Simply Wall St.

6 months ago

Autolus Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Call Highlights: Strong US Launch and ...
AUTL

GuruFocus.com

6 months ago

Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Call Highlights: Strong US Launch and ...

Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates
AUTL

GlobeNewswire

6 months ago

Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates

Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Report Preview: What to Expect
AUTL

GuruFocus.com

6 months ago

Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Report Preview: What to Expect

Autolus Therapeutics confirms license of Aucatzyl issued by U.K. MHRA
AUTL

TipRanks

7 months ago

Autolus Therapeutics confirms license of Aucatzyl issued by U.K. MHRA

AUTL

MT Newswires

7 months ago

Autolus Gets Conditional Marketing Authorization for Aucatzyl to Treat Relapsed Leukemia

Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1)
AUTL

GlobeNewswire

7 months ago

Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1)

Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
AUTL

GlobeNewswire

7 months ago

Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event

Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
AUTL

GlobeNewswire

7 months ago

Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025

April 2025's Top Penny Stocks To Watch
AUTL

Simply Wall St.

7 months ago

April 2025's Top Penny Stocks To Watch

Autolus Therapeutics price target lowered to $10 from $11 at Truist
AUTL

TipRanks

7 months ago

Autolus Therapeutics price target lowered to $10 from $11 at Truist

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
AUTL

GlobeNewswire

7 months ago

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025
AUTL

GlobeNewswire

7 months ago

Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025

AUTL

MT Newswires

8 months ago

Truist Adjusts Price Target on Autolus Therapeutics to $10 From $11, Maintains Buy Rating

What To Expect From Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings
AUTL

GuruFocus.com

8 months ago

What To Expect From Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings

Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs
AUTL

GuruFocus.com

8 months ago

Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs

AUTL

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Autolus Therapeutics PLC Earnings Call

Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
AUTL

GlobeNewswire

8 months ago

Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025
AUTL

GlobeNewswire

8 months ago

Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025

Is Autolus Therapeutics plc (AUTL) the Best UK Growth Stock to Buy Now?
AUTL

Insider Monkey

8 months ago

Is Autolus Therapeutics plc (AUTL) the Best UK Growth Stock to Buy Now?

Autolus Therapeutics to Participate in Upcoming Investor Conferences
AUTL

GlobeNewswire

8 months ago

Autolus Therapeutics to Participate in Upcoming Investor Conferences

Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings
AUTL

GlobeNewswire

10 months ago

Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings

Autolus Therapeutics Provides Business Updates and 2025 Overview
AUTL

GlobeNewswire

10 months ago

Autolus Therapeutics Provides Business Updates and 2025 Overview

Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now?
AUTL

Insider Monkey

a year ago

Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now?

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024

Autolus Therapeutics plc (AUTL): A Bull Case Theory
AUTL

Insider Monkey

a year ago

Autolus Therapeutics plc (AUTL): A Bull Case Theory

Autolus Therapeutics Announces Publication of Data from the FELIX study of obe-cel in r/r Adult B-ALL Patients in The New England Journal of Medicine
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics Announces Publication of Data from the FELIX study of obe-cel in r/r Adult B-ALL Patients in The New England Journal of Medicine

Autolus Therapeutics upgraded to Buy from Neutral at Goldman Sachs
AUTL

TipRanks

a year ago

Autolus Therapeutics upgraded to Buy from Neutral at Goldman Sachs

AUTL

MT Newswires

a year ago

Goldman Sachs Upgrades Autolus Therapeutics to Buy From Neutral, Adjusts Price Target to $7.60 From $7

Autolus Therapeutics Third Quarter 2024 Earnings: US$0.31 loss per share (vs US$0.26 loss in 3Q 2023)
AUTL

Simply Wall St.

a year ago

Autolus Therapeutics Third Quarter 2024 Earnings: US$0.31 loss per share (vs US$0.26 loss in 3Q 2023)

AUTL

MT Newswires

a year ago

Redburn Atlantic Upgrades Autolus Therapeutics to Buy From Neutral, Price Target is $13

AUTL

GuruFocus.com

a year ago

Syncona Ltd (LSE:SYNC) Half Year 2025 Earnings Call Highlights: Navigating Market Challenges ...

Autolus Therapeutics PLC (AUTL) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
AUTL

GuruFocus.com

a year ago

Autolus Therapeutics PLC (AUTL) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

AUTL

Thomson Reuters StreetEvents

a year ago

Q3 2024 Autolus Therapeutics PLC Earnings Call

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

These Stocks Moved the Most Today: Tesla, DJT, Coinbase, MARA, Cigna, Humana, AbbVie, Super Micro, and More
AUTL

Barrons.com

a year ago

These Stocks Moved the Most Today: Tesla, DJT, Coinbase, MARA, Cigna, Humana, AbbVie, Super Micro, and More

These Stocks Are Moving the Most Today: Tesla, DJT, Coinbase, MARA, Cigna, Humana, AbbVie, Super Micro, and More
AUTL

Barrons.com

a year ago

These Stocks Are Moving the Most Today: Tesla, DJT, Coinbase, MARA, Cigna, Humana, AbbVie, Super Micro, and More

Autolus secures FDA approval for CAR-T cell therapy use in ALL
AUTL

Pharmaceutical Technology

a year ago

Autolus secures FDA approval for CAR-T cell therapy use in ALL

AUTL

MT Newswires

a year ago

Sector Update: Health Care Stocks Mixed Premarket Monday

What To Expect From Autolus Therapeutics PLC (AUTL) Q3 2024 Earnings
AUTL

GuruFocus.com

a year ago

What To Expect From Autolus Therapeutics PLC (AUTL) Q3 2024 Earnings

FDA approves new CAR-T competitor to Gilead’s Tecartus
AUTL

BioPharma Dive

a year ago

FDA approves new CAR-T competitor to Gilead’s Tecartus

AUTL

MT Newswires

a year ago

Autolus Therapeutics' Leukemia Treatment Receives US FDA Approval

Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations

Further weakness as Autolus Therapeutics (NASDAQ:AUTL) drops 21% this week, taking five-year losses to 71%
AUTL

Simply Wall St.

a year ago

Further weakness as Autolus Therapeutics (NASDAQ:AUTL) drops 21% this week, taking five-year losses to 71%

Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Autolus Therapeutics (AUTL): High-Growth UK Stock in Cancer Therapy
AUTL

Insider Monkey

a year ago

Autolus Therapeutics (AUTL): High-Growth UK Stock in Cancer Therapy

Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress

Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts
AUTL

Insider Monkey

a year ago

Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts

Autolus Therapeutics PLC (AUTL) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
AUTL

GuruFocus.com

a year ago

Autolus Therapeutics PLC (AUTL) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer

AUTL

MT Newswires

a year ago

Autolus Therapeutics to Amend Lease at Nucleus Manufacturing Facility in UK

Autolus Therapeutics PLC (AUTL): Fast-Growing Penny Stock To Consider
AUTL

Insider Monkey

a year ago

Autolus Therapeutics PLC (AUTL): Fast-Growing Penny Stock To Consider

Autolus Therapeutics plc (AUTL): The Best Multibagger Penny Stock of 2025?
AUTL

Insider Monkey

a year ago

Autolus Therapeutics plc (AUTL): The Best Multibagger Penny Stock of 2025?

Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024

Autolus Therapeutics (NASDAQ:AUTL) Is In A Good Position To Deliver On Growth Plans
AUTL

Simply Wall St.

a year ago

Autolus Therapeutics (NASDAQ:AUTL) Is In A Good Position To Deliver On Growth Plans

AUTL

MT Newswires

a year ago

Autolus Therapeutics Q2 Loss Narrows; Shares Fall

Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
AUTL

GlobeNewswire

a year ago

Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Share on Social Networks: